The inhibition of specific inflammatory cytokines such as a tumor necrosis factor (TNF), migration inhibitory factor (MIF), or high mobility group box (HMGB)-1 provided promising results in experimental sepsis (7, 10–13), but, they failed in the clinical trials for sepsis (14). The gene discussed is HMGB1; the disease is Sepsis.